Analyst Ratings For NeuroDerm (NASDAQ:NDRM)
Today, Deutsche Bank AG initiated coverage on NeuroDerm (NASDAQ:NDRM) with a Buy.
There are 1 hold rating, 6 buy ratings on the stock.
The current consensus rating on NeuroDerm (NASDAQ:NDRM) is Buy (Score: 2.86) with a consensus target price of $45.80 per share, a potential 47.74% upside.
Some recent analyst ratings include
- 7/21/2017-Deutsche Bank AG initiated coverage with a Buy rating.
- 6/14/2017-CIBC Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 6/14/2017-Oppenheimer Holdings, Inc. Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 4/24/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 3/7/2017-Citigroup Inc. was Downgraded by analysts at Citigroup Inc. from a “Outperform ” rating to a ” Market Perform” rating.
Recent Trading Activity for NeuroDerm (NASDAQ:NDRM)
Shares of NeuroDerm closed the previous trading session at 31.00 down -0.20 -0.64% with 69,659 shares trading hands.